UBS Thinks AbbVie's Valuation Is 'Interesting'
February 02, 2015 at 11:18 AM EST
UBS commented on AbbVie Inc (NYSE: ABBV) Friday and maintained a Buy rating with a $76 price target following the company’s Q4 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.